BRIEF-Ligand Pharma And Glenmark Pharma Enter Into License Agreement By: Reuters: Company News January 11, 2018 at 09:06 AM EST * LIGAND ENTERS INTO WORLDWIDE OMNIAB® PLATFORM LICENSE AGREEMENT WITH GLENMARK PHARMACEUTICALS Read More >> Related Stocks: Ligand Pharm